Advances in Intensity Modulated Proton Therapy for Head and Neck Cancer Treatment

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Head and Neck Oncology".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 210

Special Issue Editor

E-Mail Website
Guest Editor
Director of Medical Physics, Lynn Cancer Institute—Radiation Oncology, Boca Raton Regional Hospital, Baptist Health South Florida, 701 NW 13 Street, Boca Raton, FL, USA
Interests: intensity modulated proton therapy; proton arc therapy; adaptive proton therapy

Special Issue Information

Dear Colleagues,

Proton therapy can improve the treatment outcomes for patients with head and neck cancer while minimizing the side effects. Moreover, recent advances in proton therapy technology, including image-guided techniques and intensity modulated proton therapy (IMPT), have further enhanced its efficacy and safety in treating head and neck cancer. We encourage submissions that explore the latest research findings in proton therapy for head and neck cancer. Manuscripts may cover topics including, but not limited to, the treatment protocols, patients’ outcomes, comparative studies, technology innovations, and the radiobiological and dosimetric considerations of proton therapy for head and neck cancer.

I look forward to receiving your contributions.

Dr. Suresh Rana
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • head and neck cancer
  • IMPT
  • proton arc
  • proton therapy
  • clinical outcome
  • dosimetry

Published Papers

This special issue is now open for submission.
Back to TopTop